PEDRO
GONZALEZ MENENDEZ
Investigador/a
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (2)
2024
-
Signaling, cancer cell plasticity, and intratumor heterogeneity
Cell Communication and Signaling
-
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Cell Communication and Signaling, Vol. 22, Núm. 1